Scholarlink

<p>Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive malignancy localized to the neuroaxis. It predominantly affects infants and young children, with exceedingly rare occurrences in adolescents and young adults. While its central nervous system (CNS) dissemination is common, extraneural metastases are exceptionally rare. We present a case of brain ATRT in a 16-year-old patient who, 8 months after the initial remission, developed an extraneural relapse involving visceral and skeletal sites. This unusual presentation posed significant diagnostic challenges in differentiating relapse from a second primary rhabdoid neoplasm. Comparative genomic analysis using a multigene panel found identical mutations in both the primary CNS tumor and a relapsed lesion, confirming their common clonal origin and ruling out a second de novo malignancy. Our case underscores the importance of awareness about the possibility of systemic relapse of ATRT. To our knowledge, this is the first report of applying comparative genomic profiling to discriminate between metastatic relapse and a second primary. Larger studies are needed to validate this approach in diverse tumor types.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Atypical teratoid rhabdoid tumor with extraneural metastases: a case report with genomic analysis

  • 期刊论文

  • 发表日期：

    2025年12月11日

查看全文
  • Nausheen Yaqoob,
  • Boris Itkin,
  • Syeda Sara Tajammul,
  • Muna Mubarak Al Jabri,
  • Zahida Niaz,
  • Ravikanth Balaji,
  • Ahmed Al Azri,
  • Ibrahim Hassan Alhaddabi,
  • Shoaib Al-Zadjali,
  • Prashant Deshpande

摘要

Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive malignancy localized to the neuroaxis. It predominantly affects infants and young children, with exceedingly rare occurrences in adolescents and young adults. While its central nervous system (CNS) dissemination is common, extraneural metastases are exceptionally rare. We present a case of brain ATRT in a 16-year-old patient who, 8 months after the initial remission, developed an extraneural relapse involving visceral and skeletal sites. This unusual presentation posed significant diagnostic challenges in differentiating relapse from a second primary rhabdoid neoplasm. Comparative genomic analysis using a multigene panel found identical mutations in both the primary CNS tumor and a relapsed lesion, confirming their common clonal origin and ruling out a second de novo malignancy. Our case underscores the importance of awareness about the possibility of systemic relapse of ATRT. To our knowledge, this is the first report of applying comparative genomic profiling to discriminate between metastatic relapse and a second primary. Larger studies are needed to validate this approach in diverse tumor types.